dOFM was successfully used to measure a therapeutic antibody (secukinumab) and inflammatory markers in healthy and lesional skin of patients with psoriasis
In an FDA (Food and Drug Administration) co-funded project we have developed a methodology to determine bioequivalence of topical drugs
cOFM was successfully used to measure substance transport enhanced by nanocarriers across the blood-brain barrier
aOFM was successfully used to measure insulin concentrations and time-resolved profiles in a clinical trial
Please reach out and we will answer
your questions, react to your ideas and
deal with your requirements.
Stay in touch